0001634389-15-000003.txt : 20150226
0001634389-15-000003.hdr.sgml : 20150226
20150226145634
ACCESSION NUMBER: 0001634389-15-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20150226
DATE AS OF CHANGE: 20150226
EFFECTIVENESS DATE: 20150226
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lyric Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001634389
IRS NUMBER: 464246084
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-234847
FILM NUMBER: 15651949
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BLVD., SUITE 1020
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-277-5437
MAIL ADDRESS:
STREET 1: 601 GATEWAY BLVD., SUITE 1020
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
D
1
primary_doc.xml
X0707
D
LIVE
0001634389
Lyric Pharmaceuticals Inc.
601 Gateway Blvd., Suite 1020
South SAN FRANCISCO
CA
CALIFORNIA
94080
415 277-5437
DELAWARE
None
None
Corporation
true
2013
David
Wurtman
c/o Lyric Pharmaceuticals Inc.
601 Gateway Blvd., Suite 1020
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Director
Kevin
Lalande
c/o Lyric Pharmaceuticals Inc.
601 Gateway Blvd, Suite 1020
South San Francisco
CA
CALIFORNIA
94080
Director
Niall
O'Donnell
c/o Lyric Pharmaceuticals Inc.
601 Gateway Blvd, Suite 1020
San Francisco
CA
CALIFORNIA
94080
Director
Jason
Hong
c/o Lyric Pharmaceuticals Inc.
601 Gateway Blvd., Suite 1020
South San Francisco
CA
CALIFORNIA
94080
Director
Sanford
Zweifach
c/o Lyric Pharmaceuticals Inc.
601 Gateway Blvd., Suite 1020
South San Francisco
CA
CALIFORNIA
94080
Director
M.
Scott
Harris
c/o Lyric Pharmaceuticals Inc.
601 Gateway Blvd., Suite 1020
South San Francisco
CA
CALIFORNIA
94080
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2015-02-11
false
true
false
0
21306689
7814562
13492127
$314,562 of the total amount sold is comprised of the conversion of principal and accrued interest in connection with outstanding convertible promissory notes.
false
12
0
0
0
false
Lyric Pharmaceuticals Inc.
/s/ Glen Sato
Glen Sato
Secretary
2015-02-23